Loading...

PE anti-mouse CD135 Antibody

Pricing & Availability
Clone
A2F10 (See other available formats)
Regulatory Status
RUO
Other Names
Flk-2, Flt3, Ly-72
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
A_A2F10_PE_102309
Bone marrow cells from C57BL/6 mouse stained with A2F10 PE and CD45R/B220 (RA3-6B2) FITC
  • A_A2F10_PE_102309
    Bone marrow cells from C57BL/6 mouse stained with A2F10 PE and CD45R/B220 (RA3-6B2) FITC
  • B_A2F10_PE_102309
    Bone marrow cells from C57BL/6 mouse stained with rat IgG2a, k PE and CD45R/B220 (RA3-6B2) FITC
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
135305 50 µg $117
Check Availability


Need larger quantities of this item?
Request Bulk Quote
135306 200 µg $335
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD135, also known as Flk-2, Flt3, and Ly-72, is a type III tyrosine kinase receptor. It is expressed on early B lymphoid lineage cells in bone marrow, on primitive myeloid progenitors within the BM CD34+ cell population. Ligation of Flk-2 with Flt3 ligand regulates the growth of hematopoietic stem cells and promotes the survival of primitive hematopoietic progenitor cells with myeloid as well as B lymphoid potential. It was reported that the receptor tyrosine kinase Flt3 is required for dendritic cell development. Combined signaling through interleukin-7 receptors and Flt3 selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse Flt3 transfected cell line
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application References

(PubMed link indicates BioLegend citation)
  1. Sergejeva S, et al. 2004. Blood 103:1270.
  2. Auffray C, et al. 2009. J. Exp. Med. 206:595.
  3. Chiba H, et al. 2013. Am J Physiol Cell Physiol. 305:693. PubMed
Product Citations
  1. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  2. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  3. Turecamo SE, et al. 2018. Matrix Biol. 67:01:00. PubMed
  4. Delbridge AR, et al. 2017. Cell Death Dis. 8:e2914. PubMed
  5. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  6. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  7. Hu X, et al. 2016. Nat Commun. 7:13095. PubMed
  8. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  9. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  10. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  11. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  12. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  13. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  14. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  15. Kinkel SA, et al. 2022. iScience. 25:104684. PubMed
  16. Carpenter RS, et al. 2020. Nat Commun. 3.029166667. PubMed
  17. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  18. Di Genua C, et al. 2020. Cancer Cell. 37(5):690-704.e8.. PubMed
  19. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  20. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  21. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  22. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  23. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  24. Qian J, et al. 2021. Int J Mol Sci. 22:. PubMed
  25. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  26. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  27. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  28. Fang H, et al. 2020. Nat Commun. 4.661805556. PubMed
  29. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  30. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  31. Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed
  32. van den Berk P, et al. 2020. Cell Rep. 33:108533. PubMed
  33. Sabnis A, et al. 2009. PLoS One. 7:e59. PubMed
  34. Kim SK, et al. 2018. Genes Dev. 32:849. PubMed
  35. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  36. Viaud M, et al. 2020. Cell Reports. 30(10):3397-3410. PubMed
  37. Jackson JT, et al. 2018. Blood Adv. 2:347. PubMed
  38. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  39. Dingler FA, et al. 2020. Mol Cell. . PubMed
  40. Giotopoulos G, et al. 2015. J Exp Med. 212: 1551-1569. PubMed
  41. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  42. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
RRID
AB_1877218 (BioLegend Cat. No. 135305)
AB_1877217 (BioLegend Cat. No. 135306)

Antigen Details

Structure
A 135-150 kD molecule belonging to the tyrosine kinase receptor family.
Distribution

Expressed on early B lymphoid lineage cells in juvenile and adult bone marrow, primitive myeloid progenitors within the BM CD34+ cell population.

Function
Regulate the growth of hematopoietic stem cells and promote the survival of primitive hematopoietic progenitor cells.
Ligand/Receptor
Flk-2/FLT3 ligand
Cell Type
B cells, Hematopoietic stem and progenitors
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Waskow C, et al.Nat. Immunol. 9:676
2. Veiby OP, et al. 1996. Blood 88(4):1256
3. Veiby OP, et al. 1996. J. Immunol. 157(7):2953
4. Mattews W, et al. 1991. Cell. 65(7):1143
5. Hannum C, et al. 1994. Nature 368(2):643
6. Ogawa M, et al. 1998. Exp Hematol. 26(6):478

Gene ID
14255 View all products for this Gene ID
UniProt
View information about CD135 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account